Johnson & Johnson reached a strategic agreement with Sail Biomedicines to obtain the exclusive option to acquire the company for US$2.58 billion and simultaneously make equity investments; the total initial payment was US$785 million.

Zhitongcaijing · 1d ago
Johnson & Johnson reached a strategic agreement with Sail Biomedicines to obtain the exclusive option to acquire the company for US$2.58 billion and simultaneously make equity investments; the total initial payment was US$785 million.